4FD9ED95-21E7-440D-AAA9-86DDDF12B37A
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 21.38633377135348
- age_years
- 51
- sex
- Female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR934749 | — | — | 0.954 |
| 2 | CA366342-0949-4941-8AE6-984BAF032886 | — | — | 0.937 |
| 3 | SRR934880 | — | — | 0.936 |
| 4 | C6A16A8F-0AB7-42E9-A068-15EECF2912D3 | — | — | 0.933 |
| 5 | 4938761D-0762-4984-A399-BC036D6D2140 | — | — | 0.926 |
| 6 | 293E6D35-8392-4C44-BC18-F917989516B0 | — | — | 0.920 |
| 7 | 0D1652B9-93F6-4D1A-BF06-B654663C92E3 | — | — | 0.919 |
| 8 | 74897E26-10A5-4484-A867-CE7C86DDB7E2 | — | — | 0.919 |
| 9 | SRR934879 | — | — | 0.917 |
| 10 | CEEF1D8C-DC91-4862-86A0-F345C2C770C0 | — | — | 0.908 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 16 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| MYC_TARGETS_V2 | 0.557 | Idelalisib | — uncovered |
| MYC_TARGETS_V1 | 0.507 | Inavolisib | — uncovered |
| E2F_TARGETS | 0.497 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.488 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.421 | Idelalisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.302 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.292 | Remibrutinib | — uncovered |
| MITOTIC_SPINDLE | 0.258 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.224 | Idelalisib | — uncovered |
| NOTCH_SIGNALING | 0.172 | Inavolisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.169 | Remibrutinib | — uncovered |
| TGF_BETA_SIGNALING | 0.148 | Inavolisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.102 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.022 | Remibrutinib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.016 | Inavolisib | — uncovered |
| MTORC1_SIGNALING | 0.008 | Inavolisib | — uncovered |